- Home
- CORT vs JHG Comparison
CORT vs JHG Comparison
Compare CORT & JHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- JHG
- Stock Information
- Founded
- CORT 1998
- JHG 1934
- Country
- CORT United States
- JHG United Kingdom
- Employees
- CORT N/A
- JHG N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- JHG Investment Managers
- Sector
- CORT Health Care
- JHG Finance
- Exchange
- CORT Nasdaq
- JHG Nasdaq
- Market Cap
- CORT 7.6B
- JHG 7.0B
- IPO Year
- CORT N/A
- JHG N/A
- Fundamental
- Price
- CORT $80.94
- JHG $42.76
- Analyst Decision
- CORT Strong Buy
- JHG Buy
- Analyst Count
- CORT 5
- JHG 8
- Target Price
- CORT $139.00
- JHG $47.88
- AVG Volume (30 Days)
- CORT 639.6K
- JHG 1.1M
- Earning Date
- CORT 11-04-2025
- JHG 10-30-2025
- Dividend Yield
- CORT N/A
- JHG 3.74%
- EPS Growth
- CORT N/A
- JHG 33.81
- EPS
- CORT 0.87
- JHG 3.39
- Revenue
- CORT $741,172,000.00
- JHG $2,663,300,000.00
- Revenue This Year
- CORT $28.85
- JHG $12.36
- Revenue Next Year
- CORT $34.98
- JHG $8.42
- P/E Ratio
- CORT $91.92
- JHG $12.61
- Revenue Growth
- CORT 17.92
- JHG 14.14
- 52 Week Low
- CORT $49.00
- JHG $28.26
- 52 Week High
- CORT $117.33
- JHG $49.42
- Technical
- Relative Strength Index (RSI)
- CORT 61.15
- JHG 46.88
- Support Level
- CORT $73.79
- JHG $41.92
- Resistance Level
- CORT $78.99
- JHG $43.57
- Average True Range (ATR)
- CORT 3.03
- JHG 1.04
- MACD
- CORT 0.61
- JHG -0.05
- Stochastic Oscillator
- CORT 95.41
- JHG 41.43
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About JHG Janus Henderson Group plc
Janus Henderson Group provides investment management services to retail intermediary (49% of managed assets), self-directed (20%) and institutional (31%) clients. At the end of June 2025, active equities (53%), fixed-income (31%), balanced (12%) and alternative (4%) investment platforms constituted the company's $457.3 billion in assets under management. Janus Henderson sources most of its managed assets from clients in North America (66%), with customers from Europe, the Middle East, Africa, and Latin America (25%) and the Asia-Pacific region (9%) accounting for the remainder.